BioSpace News Archive

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura™

Cerevel Therapeutics announced today that Kathy Yi has resigned her position as chief financial officer to pursue other personal and professional interests.

On World Alzheimer’s Day, Missouri leaders and economic development officials praise C₂N Diagnostics for deciding to continue to grow its St. Louis-based company which is receiving international recognition for developing and accelerating novel diagnostics and therapies for Alzheimer’s disease.

Medexus Pharmaceuticals Inc. announced today that it has initiated its first commercial shipment of Trecondyv® (treosulfan) in Canada.

Phase 2 clinical results with HTD1801, a novel orally active ionic salt of berberine and ursodeoxycholic acid, substantially reduced liver fat while improving glycemic control and other cardiometabolic biomarkers in adults with nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2DM), have been published online in Nature Communications by HighTide Therapeutics.

LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack® assisted system, the LUMESEAL® laser platform.

Persephone Biosciences Inc., today announced that it has entered into a collaboration agreement with Janssen Biotech, Inc.

Accutar Biotechnology, Inc . today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for AC0682 for the treatment of patients with estrogen receptor (ER)-positive breast cancers.

The World Health Organization has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology in their 2021 compendium, “WHO compendium of innovative health technologies for low-resource settings”.

GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company, announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset the largest of its kind in the world.